test 10 part 2 Flashcards

1
Q

Complement System

A
  • part of the innate immunity
     Defense mechanism brought into play nonspecifically in response to invading organisms
     “Complements” the actions of antibodies
     Primary mechanism activated by antibodies to kill foreign cells
  • enzyme precursors (trigger one you trigger them all)
     End products work to prevent / limit damage from invading organism or toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classical pathway initiated by

A

 Antigen-antibody complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alternative pathway initiated by

A

 C3b (a product of the classical pathway)
 Spontaneous activation on a continuous basis
 Feedback loop for amplification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Terminal Pathway initiated by

A

 Classical and Alternative merge at the level of C3 convertase production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Complement activation results in

A
  • Recruitment of inflammatory cells
  • Opsinization of pathogens
  • Killing of pathogens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the whole goal of the complement cascade is to

A
  • Work to prevent / limit damage from invading organism or toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

complement cascade prevent / limit damage from invading organism or toxin by:

A
  • Opsonization and phagocytosis (activates neutrophils)
  • Lysis: (MAC)
  • Agglutination: which prevents invader from going anywher
  • Neutralization of viruses
  • Chemotaxis (C5a causes neutrophil and macrophage chemotaxis)
  • Activaiton of maxt cells and basophils (C3a, C4a, and C5a)
  • Inflammation (permeability and cardiac function)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Both pathways activated by cardiopulmonary bypass

A
  • cellular damage
  • endothelial and leukocyte activation
  • histamine release
  • increased vascular permeability
  • generalized inflammatory response
  • platelet activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CPB Complement Classical Pathway Activation

A
  • Surface contact activation of factor XII
  • Heparin-protamine complexes
  • Ischemia reperfusion
  • Blood-air interface
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CPB Complement Alternative Pathway Activation

A
  • Contact with foreign surface
  • Activated pericardium and suction blood
  • Ischemia reperfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

principal pathway during CPB

A
  • alternate pathway

- activated by both pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

C3a, C4a, C5a

A
  • anaphylatoxins with vasoactive properties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

C5a

A
  • major neutrophil agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

C3b, C4b

A
  • opsonization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Terminal complement complex

A
  • accelerates thrombin formation via action on prothrombinase complex
  • activates platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 types of blood cells

A
  • Platelets
  • Neutrophils
  • Monocytes
  • Lymphocytes
  • Endothelial Cells
17
Q

Platelets – Initial / Early Activation

A
  • Surface contact with ECC
  • Heparin : increases sensitivity
  • Circulating thrombin
    - powerful agonist and probably initial activator
  • Platelet-activating factor (PAF)
18
Q

Platelets – Late Activation

A
  • Activated Complement (C5b – C9)
  • Plasmin
  • Hypothermia
  • Interleukin-6
  • Cathepsin G (protein in neutrophils to aid in killing engulfed pathogen)
  • Serotonin
  • Epinephrine
19
Q

Platelets – Response to Activation

A
  • Immediate shape change

- express surface receptors (GPIIb/IIIa)

20
Q

Neutrophil – Very Strong Activation

A
  • Principal agonists - kallikrein and C5a
  • release contents of granules
  • Express MAC
  • Express selectin receptor
  • Major role in ischemia-reperfusion injury & responsible for much of inflammatory response associate with bypass
21
Q

Monocyte Activation

A
  • Slow activation during CPB by : C5a, thrombin, and bradykinin
  • Activated in wound and circuit
  • Produce and release cytokines (IL’s)
22
Q

Lymphocyte Response

A
  • Number of cells - reduced first week after bypass (increases chance of infection)
23
Q

Endothelial Cell Activation agents

A
  • thrombin, C5a, various cytokines, TNF
24
Q

Activated endothelial cells express various receptors

A
  • tissue factor and selectin
25
Q

What do Activated Endothelial Cells do

A
  • Synthesize tissue factor to generate thrombin
  • Initiate fibrinolysis
  • Contribute to the overall acute inflammatory response
  • Allow fluid and leukocytes to enter the interstitial space
26
Q

Control of Blood-Surface Interface

A
  • Develop biomaterial that mimics the endothelial cell layer
  • Prevent or block activation of the blood during bypass
  • limit activation of blood
27
Q

Surface-Bound Heparin

A
  • ionic (weak)
  • covalent (strong) : we want this so it doesn’t go into the blood stream
  • claims to provide much better outcomes
28
Q

Terumo X CoatingTM

A
  • Non-heparin coating
  • Reduced protein denaturing and platelet adhesion
  • Good for heparin sensitivities
  • Can be applied to all types of materials
29
Q

Medtronic CarmedaTM

A
  • Gold Standard
  • Everything can be coated with it
  • Problem : it uses heparin
  • Less blood products use
  • Less perioperative blood loss
  • Shorter ventilator time
  • Shorter hospital stay
  • Reduced impact on contact, coagulation, fibrinolytis, complement and cytokines
  • Reduced impact on platelets, rbc, leukocytes
30
Q

Medtronic Trillium Biosurface

A
  • Negative charge surface
  • Heparin coated
  • Hydrophilic = body wants to interact => mimics the endothelium
31
Q

Medtronic Balance® Biosurface

A
  • Negative charge surface
  • Non-Heparin coated
  • Hydrophilic = body wants to interact => mimics the endothelium
32
Q

Maquet Bioline

A
  • Mimics endothelium
  • Albumin and Heparin coated
  • doesn’t want to interact with platelets and also takes up
33
Q

Maquet Softline

A
  • Mimics endothelium
  • Albumin coated but no heparin
  • doesn’t want to interact with platelets and also takes up
34
Q

Sorin P.h.i.s.i.o

A
  • Based on phosphorylcholine molecule
  • Stable and durable
  • Improves platelet preservation
  • Reduces activation of coagulation factors
  • Reduces inflammatory reactions
  • Limits post operative blood loss
35
Q

other than altering our circuit, what else can we do to help our clotting factors and platelets

A
  • give corticosteroids
  • colloid priming (keeps water in the casculature)
  • antifibrinolytic agents
  • platelet anesthesia
  • complement inhibitors
36
Q

other than altering our circuit, what pump modifications can we do to help our clotting factors and platelets

A
  • Centrifugal pump
  • Pulsatile flow
  • Mini circuits
  • Off pump
  • Ultrafiltration
  • Leukodepletion
  • Shed blood management